Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Tenax Therapeutics, Inc. (TENX) had Free Cash Flow per Share of $-0.21 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-15.72M |
|
-- |
|
-- |
|
$16.57M |
|
$-16.57M |
|
$0.86M |
|
$-15.72M |
|
$-15.72M |
|
$-15.72M |
|
$-15.72M |
|
$-15.72M |
|
$-15.72M |
|
$-16.57M |
|
$-16.57M |
|
45.23M |
|
45.23M |
|
$-0.35 |
|
$-0.35 |
|
| Balance Sheet Financials | |
$123.18M |
|
-- |
|
-- |
|
$123.18M |
|
$8.49M |
|
-- |
|
-- |
|
$8.49M |
|
$114.69M |
|
$114.69M |
|
$114.69M |
|
24.28M |
|
| Cash Flow Statement Financials | |
$-9.31M |
|
-- |
|
$30.50M |
|
$97.56M |
|
$118.75M |
|
$21.19M |
|
$2.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.52 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.31M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.70% |
|
-13.70% |
|
-12.76% |
|
-13.70% |
|
$4.72 |
|
|
Free Cash Flow per Share |
$-0.21 |
$-0.21 |
|